Abu Dhabi is preparing to host the Future Health Summit 2026 from October 20 to 22 at the Abu Dhabi National Exhibition Centre (ADNEC), bringing together leaders and experts from the healthcare, science, technology, artificial intelligence, genomics and investment sectors.
The summit — hosted and organised by the Future of Health – A Global Initiative from Abu Dhabi platform, under the supervision and guidance of the Department of Health – Abu Dhabi — comes as the emirate continues to develop an integrated healthcare ecosystem. The system focuses on enhancing prevention and aligning efforts across policy, data, genomics, clinical innovation and investment, creating a real-world environment for developing, testing and scaling new healthcare approaches globally.
The summit comes at a time when healthcare systems around the world are shifting rapidly from a model focused on treating disease after it emerges to a more proactive approach based on predicting risks, detecting them early and preventing them.
‘To Sense is to Predict’
Held under the theme “To Sense is to Predict”, the summit reflects the transformation being driven by artificial intelligence, data analytics, genomics and digital sensing technologies in the future of medicine and healthcare. A key focus will be on how growing volumes of health data can be transformed into actionable insights to support faster, more accurate and personalised medical decisions.
The summit agenda indicates that AI is no longer being presented as a distant technology removed from medical practice, but as a tool increasingly integrated into multiple stages of the healthcare cycle — from identifying risk indicators and early diagnosis to treatment selection, patient monitoring and chronic disease management, as well as drug discovery and personalised medicine.
AI: From diagnosis to prediction
One of the key transformations to be discussed at Future Health 2026 is the shift from using AI to analyse a patient’s condition at a specific point in time to using it to analyse a continuous stream of data and identify changes in health before they develop into a clearly defined disease.
According to the initiative’s agenda, such data includes health records, biomarkers, genetic information, wearable-device data, health behaviours, and environmental and social factors.
This approach opens the door to new models of predictive health, enabling the development of individual- and population-level health risk indicators, as well as more personalised screening and monitoring programmes.
The initiative broadly categorises these applications into three main levels. At the individual level, the focus is on identifying behavioural and psychological patterns and providing data-driven health guidance. At the health-system level, applications include risk stratification, personalised screening plans, genetic testing and molecular diagnostics. At the population level, the focus is on predicting health risks, monitoring disease patterns and assessing environmental conditions that affect public health.
Wearable devices: A 24-hour health laboratory
Among the applications gaining increasing importance is the use of AI to analyse data collected by smartwatches, bracelets, rings and other health-monitoring devices.
Rather than relying solely on a patient’s visit to a doctor or the results of a periodic medical examination, continuous data can provide a more detailed picture of changes in specific health and behavioural indicators.
Future Health, Abu Dhabi’s global health collaboration platform advancing AI and digital health, precision medicine, life sciences and resilience, notes that personal sensing technologies are increasingly capable of collecting physiological and behavioural data in real time. This allows for more personalised health guidance, while AI can be used to analyse the information and identify unusual patterns or warning signs.
The concept of “sensing” extends beyond individual devices to the community level through the integration of health, environmental and behavioural data to identify changes that may indicate shifts in the health status of populations.
Genomics and AI move towards more precise medicine
Genomics and precision medicine are emerging as areas where AI could drive significant transformation.
The ability to process vast amounts of genetic data and link it with clinical information, lifestyle data and environmental factors could help researchers and physicians identify patterns and risks that may not be readily detectable through conventional data analysis.
In this context, the Department of Health – Abu Dhabi has said its vision for the future of health is based on integrating data, genomics, clinical innovation and investment, describing the emirate as an environment where AI-powered healthcare solutions can be built, tested and scaled.
The summit agenda also includes advanced genetic testing and high-precision molecular diagnostics, linking AI with personalised medicine rather than limiting its role to conventional digital healthcare services.
Detecting disease before symptoms appear
One of the most anticipated applications of AI in healthcare is its ability to analyse multiple indicators simultaneously to identify the likelihood of certain diseases before clear symptoms emerge.
This changes the philosophy of healthcare. Instead of waiting for a disease to progress to a stage requiring intensive treatment, the objective becomes identifying potential risks at an early stage and intervening before the condition worsens.
The summit will explore this shift through sessions addressing proactive health, including the possibility of determining the optimal time for early intervention, as well as the future of cancer care, rare diseases, longevity and precision medicine.
As part of this effort, Future Health, in collaboration with MIT Solve, launched a global challenge seeking solutions to help build proactive healthcare systems based on population-level sensing. The initiative received 393 submissions from 68 countries, with technology-based solutions selected that aim to identify health risks at an earlier stage and support faster, more data-driven healthcare decision-making.
AI in drug discovery
The use of AI does not stop at hospitals and clinics. It is also extending into the pharmaceutical industry and scientific research.
One major opportunity lies in using algorithms to analyse vast databases involving chemical compounds, proteins, genetic data and clinical outcomes. This could help researchers identify potential therapeutic targets and select compounds that warrant further investigation.
In May, the Department of Health – Abu Dhabi said the emirate was working to integrate genotype, phenotype and wearable-device data into an AI-powered ecosystem to support drug discovery and use real-world data to assess the impact of health products in real time.
This reflects a broader trend towards linking medical research with real-world information generated through healthcare delivery, rather than separating research and development from the day-to-day data generated by patients and health systems.
Will AI become the ‘doctor’?
One of the notable sessions on the 2026 summit programme is titled “The Rise of the AI Physician”, alongside a session exploring how AI could redefine medicine over the next five years.
This does not necessarily mean replacing doctors. Rather, it raises questions about the evolving relationship between physicians and machines.
AI can process vast quantities of data rapidly, compare test results, medical records and biomarkers, and identify patterns that may warrant further clinical assessment. The final clinical decision, however, remains linked to medical judgement, professional responsibility and direct communication with the patient.
During the Healthcare Leaders Summit Abu Dhabi 2026, Sheikh Nahyan bin Mubarak Al Nahyan emphasised that technological advances are opening significant possibilities in diagnosis, treatment, prevention and research, while stressing the continuing human role of physicians in identifying problems, prescribing treatment and interacting with patients.
Abu Dhabi: From showcasing technology to testing it
The Future Health Summit gains additional significance from its connection to an existing healthcare ecosystem rather than functioning simply as an exhibition of future technologies.
The Department of Health – Abu Dhabi says the emirate is working to build an integrated environment bringing together policy, data, genomics, clinical innovation and investment, enabling new healthcare solutions to be tested, developed and subsequently scaled.
The Future Health initiative is also evolving into a year-round platform encompassing innovation challenges, research, policy outputs and dialogue among government entities, companies, researchers and investors, rather than being limited to a single annual event.
The 2026 edition is expected to attract around 16,000 international participants, 1,750 conference delegates, 300 speakers and more than 175 exhibitors, with participants from approximately 100 countries, according to figures released by the organiser.
The real challenge: Data and trust
As AI applications expand, questions extending beyond technology are also emerging. These include who owns health data, how it is protected, how the accuracy of AI models can be verified, and who bears responsibility when an automated system produces an incorrect recommendation.
For this reason, the summit places resilience and sustainability in healthcare systems alongside AI, precision medicine and investment in life sciences. The aim is to examine digital transformation as a transformation of the healthcare system as a whole, rather than simply the addition of new technological tools to hospitals.
The success of AI in medicine will therefore not be measured solely by an algorithm’s ability to analyse data, but by a healthcare system’s ability to translate those findings into a safe, timely, interpretable and actionable medical decision.
From treatment to prevention
Ultimately, the agenda of Abu Dhabi 2026 reflects a fundamental shift in the concept of healthcare — from asking, “How do we treat disease?” to a more proactive question: “How can we detect the likelihood of disease before it becomes a health problem?”
From wearable sensors and genetic data to molecular diagnostics, digital health records and predictive analytics, a new model is emerging that could make healthcare more data-driven and personalised.
The true value of these technologies, however, will be determined by their ability to move from laboratories and experimental platforms into trusted, scalable clinical applications while safeguarding privacy and patient safety and preserving the central role of physicians and human judgement.
This is precisely the test Abu Dhabi is placing before the future healthcare ecosystem: not merely discovering what AI can do, but demonstrating its ability to turn those capabilities into tangible health outcomes — and to move from predicting disease to preventing it.
